Allogeneic hemopoietic stem cell transplantation (BMT) after IV busulfan, and cyclophosphamide (BuCy) for acute myeloid leukemia (AML) and myelodysplasia (MDS).

被引：0
|
作者：
Andersson, BS
Cagnoni, P
Jones, R
Gian, V
Wingard, JR
Tarantolo, S
Kashyap, A
Forman, SJ
Hu, WH
Blume, KG
Fernandez, HF
Champlin, RE
机构：
[1] Univ Colorado, Boulder, CO 80309 USA
[2] Univ Florida, Gainesville, FL 32611 USA
[3] Univ Nebraska, Lincoln, NE 68583 USA
[4] Univ Miami, Coral Gables, FL 33124 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
729
引用
收藏
页码：167A / 167A
页数：1
相关论文
共 50 条
  • [41] COMPARISON OF IV BUSULFAN AND FLUDARABINE VS IV BUSULFAN AND CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN IN MYELOABALTIVE ALLOGENEIC STEM CELL TRANSPLANTATION
    de Villambrosia, S. Gonzalez
    Moreto, A.
    Nunez, J.
    Bermudez, A.
    Yanez, L.
    Insunza, A.
    Iriondo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 142 - 142
  • [42] Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Older Adults with Acute Myeloid Leukemia (AML)
    Lipof, Jodi J.
    Manogna, Dharmini
    Baran, Andrea M.
    Said, Bassil
    Becker, Michael W.
    Mendler, Jason H.
    Aljitawi, Omar S.
    O'Dwyer, Kristen Marie
    Huselton, Eric
    Burack, Richard
    Blaney, Margaret
    Douglas, Taylor
    Liesveld, Jane L.
    Loh, Kah Poh
    BLOOD, 2020, 136
  • [43] Acute myeloid leukemia (AML) and Myelodysplastic syndrome (MDS) associated with Monosomy 7: Management by allogeneic hematopoietic stem cell transplantation (HSCT)
    Giller, RH
    Trobaugh, AD
    Hunger, SP
    Malcolm, J
    Schissel, D
    Hild, E
    Quinones, RR
    PEDIATRIC RESEARCH, 2002, 51 (04) : 251A - 251A
  • [44] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE MYELOID LEUKEMIA (AML): THE TUNISIAN RESULTS
    Torjemane, L.
    Abdejlil, N.
    Lakhal, A.
    Barhoumi, W.
    Ben Hamed, L.
    Kaabi, H.
    Slama, H.
    Laamouri, A.
    Ladeb, S.
    Ben Othman, T.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S112 - S112
  • [45] Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) Not in First Remission
    Sweet, Kendra L.
    Lancet, Jeffrey E.
    Hillgruber, Ryan
    Melody, Megan
    Llishi, Amina
    Perkins, Janelle
    Fernandez, Hugo F.
    Field, Teresa
    BLOOD, 2015, 126 (23)
  • [46] Impact of disease burden at time of allogeneic stem cell transplantation (SCT) in adults with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
    Kebriaei, P
    Kline, J
    Kasza, K
    Stock, W
    Larson, RA
    van Besien, K
    BLOOD, 2003, 102 (11) : 725A - 725A
  • [47] Trends in hospitalization outcomes of elderly patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia/myelodysplastic syndrome (AML/MDS).
    Murthy, Guru Subramanian Guru
    Mehta, Paulette
    Jethava, Yogesh
    Dhakal, Ishwori
    Makhoul, Issam
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Allogeneic haematopoietic stem cell transplantation for elderly patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): A single center analysis
    Katayama, Y.
    Iwato, K.
    Ohchi, T.
    Okatani, T.
    Imanaka, R.
    Kyo, K.
    Itagaki, M.
    Katsutani, S.
    Kyo, T.
    Asaoku, H.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S475 - S476
  • [49] Lack of impact of comorbidities on outcomes of allogeneic stem cell transplantation (ASCT) for refractory acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS)
    Wong, RS
    Shahjahan, M
    Alamo, J
    de Lima, M
    Khouri, I
    Gajewski, J
    Andersson, B
    Champlin, R
    Giralt, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 31 - 31
  • [50] Outcome of allogeneic bone marrow transplantation (BMT) for children with advanced acute myeloid leukemia (AML).
    Nemecek, ER
    Gooley, TA
    Carpenter, PA
    Woolfrey, AE
    Sievers, EL
    Matthews, DC
    Sanders, JE
    BLOOD, 2002, 100 (11) : 114A - 114A
12345